| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/19/2004 | US20040161383 Diagnostic agents for pancreatic exocrine function |
| 08/19/2004 | US20040161369 Sensitive, reproducible Raman spectroscopy detector; oxidizing surface of silicon substrate; wetting with and thermally decomposing metal salt solution |
| 08/19/2004 | DE19824280B4 Mutationsanalyse mittels Massenspektrometrie Mutation analysis by mass spectrometry |
| 08/19/2004 | DE10304219B3 Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität A method for detecting cytosine methylation patterns with high sensitivity |
| 08/19/2004 | DE10036501B4 Verfahren zur Messung der JNK/SAPKs-Aktivität mittels der Bestimmung der Phosphorylierung von Transkriptionsfaktoren Method for measuring the JNK / SAPKs activity by determining the phosphorylation of transcription factors |
| 08/19/2004 | DE10006798B4 Verfahren zum Ermitteln eines biologischen Schadstoffabbaus in der Umwelt A method for detecting a biological contaminant degradation in the environment |
| 08/19/2004 | CA2773059A1 Bead emulsion nucleic acid amplification |
| 08/19/2004 | CA2743564A1 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 08/19/2004 | CA2515600A1 A culture medium and a method for detection of parasites |
| 08/19/2004 | CA2515339A1 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | CA2514983A1 Novel supported catalyst systems |
| 08/19/2004 | CA2514942A1 Methods and compositions for the treatment of parkinson's disease and other a-synucleinopathies |
| 08/19/2004 | CA2514843A1 Protein fragment complementation assays for high-throughput and high-content screening |
| 08/19/2004 | CA2514838A1 Nucleic acid antigens embedded in thermoplastic |
| 08/19/2004 | CA2514810A1 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | CA2514593A1 Improved petri dish |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2513889A1 Double ended sequencing |
| 08/19/2004 | CA2513541A1 Method for preparing single-stranded dna libraries |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/19/2004 | CA2496017A1 Microreactor architecture and methods |
| 08/18/2004 | EP1447454A1 Method and apparatus for detecting pathogens |
| 08/18/2004 | EP1447452A1 Method of detecting bias in enzyme electrode measurements |
| 08/18/2004 | EP1447448A1 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 08/18/2004 | EP1447446A1 Method of labeling nucleic acids |
| 08/18/2004 | EP1447445A1 PROBE SOLUTIN COMPOSITIONS, REACTIVE CHIP USING THE SAME AND PROCESS FOR THE PRODUCTION THEREOF |
| 08/18/2004 | EP1447413A2 Full-length human cDNA |
| 08/18/2004 | EP1447085A1 Agent controlling the production of osteoclast formation regulator and method of screening substance capable of controlling the production of osteoclast formation regulator |
| 08/18/2004 | EP1446757A2 In silico screening for phenotype-associated expressed sequences |
| 08/18/2004 | EP1446666A1 Method for detecting analyte(s) using magnetic colloidal particles |
| 08/18/2004 | EP1446508A2 A method of reducing non-specific amplification in pcr |
| 08/18/2004 | EP1446507A2 Therapeutics and diagnostics for disorders of erythropoiesis |
| 08/18/2004 | EP1446506A2 COMPOSITIONS, METHODS AND KITS FOR DETERMINING THE PRESENCE OF i MYCOPLASMA PNEUMONIAE /i AND/OR i MYCOPLASMA GENITALIUM /i IN A TEST SAMPLE |
| 08/18/2004 | EP1446504A2 Emulsion compositions |
| 08/18/2004 | EP1446502A2 Polymorphism detection and separation |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446499A2 Phosphine-containing formulations for chemiluminescent luciferase assays |
| 08/18/2004 | EP1446498A2 Protease assay for therapeutic drug monitoring |
| 08/18/2004 | EP1446497A1 Methods of screening for toxicity of test compounds |
| 08/18/2004 | EP1446496A2 Methods for ligand dicovery |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446491A1 Method for production of asymmetric carotenoids |
| 08/18/2004 | EP1446490A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446482A2 Compositions and methods for making mutations in cell lines and animals |
| 08/18/2004 | EP1446475A2 RECOMBINANT DNA PROCESSES USING A dNTP MIXTURE CONTAINING MODIFIED NUCLEOTIDES |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446416A1 Tumor specific monoclonal antibodies |
| 08/18/2004 | EP1446415A2 Detection and identification of enteric bacteria |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446412A2 Novel lna compositions and uses thereof |
| 08/18/2004 | EP1446388A1 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446044A2 Pin1 as a marker for prostate cancer |
| 08/18/2004 | EP1446013A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1379690A4 Oligonucleotide chip composition for analyzing hepatitis c virus (hcv) genotype and detecting method thereof |
| 08/18/2004 | EP1356078A4 Methods for diagnosing and treating pediatric neoplasms |
| 08/18/2004 | EP1350109A4 Marker for inflammatory conditions |
| 08/18/2004 | EP1299557A4 Signal amplification with lollipop probes |
| 08/18/2004 | EP1280603B1 Method for the identification, quantification, and visualisation of micro-organisms |
| 08/18/2004 | EP1261746A4 Method of monitoring hiv assembly and maturation |
| 08/18/2004 | EP1261724A4 Topoisomerase linker-mediated amplification methods |
| 08/18/2004 | EP1185705B1 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples |
| 08/18/2004 | EP1169641A4 Proteome mining |
| 08/18/2004 | EP1145012B1 Methods and kits for sequencing polypeptides |
| 08/18/2004 | EP1129344B1 Methods and formulations for the separation of biological macromolecules |
| 08/18/2004 | EP1129219B1 Restricted amplicon analysis |
| 08/18/2004 | EP1121457B1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 08/18/2004 | EP1098990A4 Blocked-polymerase polynucleotide immunoassay method and kit |
| 08/18/2004 | EP1075542A4 Quantitative microarray hybridization assays |
| 08/18/2004 | EP1064396A4 A selective assay for determining the identity of live microorganisms in a mixed culture |
| 08/18/2004 | EP1053474B1 Method for the determination of prosthetic infections |
| 08/18/2004 | EP1042502B1 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample |
| 08/18/2004 | EP1040202A4 Dna polymorphism identity determination using flow cytometry |
| 08/18/2004 | EP1038025A4 Genetic alterations associated with cancer |
| 08/18/2004 | EP1012257A4 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 08/18/2004 | EP1007733A4 Universal solid-phase hybridization apparatus |
| 08/18/2004 | EP1005533A4 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 08/18/2004 | EP0983384A4 A method of diagnosing abnormal cell growth |
| 08/18/2004 | EP0951533A4 Vectors and methods for the mutagenesis of mammalian genes |
| 08/18/2004 | EP0931163A4 Assessment of intracellular cysteine and glutathione concentrations |
| 08/18/2004 | EP0881914B1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression |
| 08/18/2004 | EP0862622B1 Method of screening for RAC protein kinase interacting compounds |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0805870A4 Spectroscopically detectable nucleic acid ligands |
| 08/18/2004 | EP0804587B1 Mutant luciferases |
| 08/18/2004 | EP0758401A4 Dry prothrombin time assay |
| 08/18/2004 | EP0742836A4 Method for separating rare cells from a population of cells |
| 08/18/2004 | EP0698791B1 Method of determining cholesterol in high-density lipoprotein |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | CN1522365A 生物传感器 Biosensor |
| 08/18/2004 | CN1522305A Amplification process |
| 08/18/2004 | CN1522304A Use of a biochip for the diagnosis of sepsis or sepsis related syndrome |
| 08/18/2004 | CN1522303A Method for detecting a risk of hypertension and uses thereof |
| 08/18/2004 | CN1522302A Method of colorimetry and reagent for use therein |
| 08/18/2004 | CN1521500A Low voltage and low power thermal bubble film type microfluid driving device |